A citation-based method for searching scientific literature

Julio Rosenstock, Antonio Nino, Joseph Soffer, Lois Erskine, Andre Acusta, Jo Dole, Molly C Carr, Jason Mallory, Philip Home. Diabetes Care 2020
Times Cited: 11







List of co-cited articles
59 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes.
Michaela Diamant, Michael A Nauck, Rimma Shaginian, James K Malone, Simon Cleall, Matthew Reaney, Danielle de Vries, Byron J Hoogwerf, Leigh MacConell, Bruce H R Wolffenbuttel. Diabetes Care 2014
153
27

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetes Care 2018
27

Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro.
Julio Rosenstock, Vivian A Fonseca, Jorge L Gross, Robert E Ratner, Bo Ahrén, Francis C C Chow, Fred Yang, Diane Miller, Susan L Johnson, Murray W Stewart,[...]. Diabetes Care 2014
167
27

A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON).
C Mathieu, H W Rodbard, B Cariou, Y Handelsman, A Philis-Tsimikas, A M Ocampo Francisco, A Rana, B Zinman. Diabetes Obes Metab 2014
123
27

Estimation of global insulin use for type 2 diabetes, 2018-30: a microsimulation analysis.
Sanjay Basu, John S Yudkin, Sylvia Kehlenbrink, Justine I Davies, Sarah H Wild, Kasia J Lipska, Jeremy B Sussman, David Beran. Lancet Diabetes Endocrinol 2019
68
27



Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial.
Helena W Rodbard, Ildiko Lingvay, John Reed, Raymond de la Rosa, Ludger Rose, Danny Sugimoto, Eiichi Araki, Pei-Ling Chu, Nelun Wijayasinghe, Paul Norwood. J Clin Endocrinol Metab 2018
112
27

Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide.
Jesper Lau, Paw Bloch, Lauge Schäffer, Ingrid Pettersson, Jane Spetzler, Jacob Kofoed, Kjeld Madsen, Lotte Bjerre Knudsen, James McGuire, Dorte Bjerre Steensgaard,[...]. J Med Chem 2015
352
18


Deintensification in older patients with type 2 diabetes: A systematic review of approaches, rates and outcomes.
Samuel Seidu, Setor K Kunutsor, Pinar Topsever, Clare E Hambling, Francesc X Cos, Kamlesh Khunti. Diabetes Obes Metab 2019
19
18

Simplifying Complex Insulin Regimens While Preserving Good Glycemic Control in Type 2 Diabetes.
Zoltán Taybani, Balázs Bótyik, Mónika Katkó, András Gyimesi, Tamás Várkonyi. Diabetes Ther 2019
9
22

The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials.
Maria Ida Maiorino, Paolo Chiodini, Giuseppe Bellastella, Lorenzo Scappaticcio, Miriam Longo, Dario Giugliano, Katherine Esposito. Diabetes Res Clin Pract 2019
9
22

Beyond basal-bolus insulin regimen: Is it still the ultimate chance for therapy in diabetes?
Dario Giugliano, Giuseppe Bellastella, Maria Ida Maiorino, Katherine Esposito. Diabetes Res Clin Pract 2019
4
50

Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Maria Ida Maiorino, Paolo Chiodini, Giuseppe Bellastella, Annalisa Capuano, Katherine Esposito, Dario Giugliano. Diabetes Care 2017
62
18

Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013.
Kasia J Lipska, Xiaoxi Yao, Jeph Herrin, Rozalina G McCoy, Joseph S Ross, Michael A Steinman, Silvio E Inzucchi, Thomas M Gill, Harlan M Krumholz, Nilay D Shah. Diabetes Care 2017
177
18

Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes.
Olga Montvida, Jonathan Shaw, John J Atherton, Frances Stringer, Sanjoy K Paul. Diabetes Care 2018
130
18

Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes.
D Giugliano, M I Maiorino, G Bellastella, K Esposito. J Endocrinol Invest 2019
28
18

Use of liposomes to aid intestinal absorption of entrapped insulin in normal and diabetic dogs.
H M Patel, R W Stevenson, J A Parsons, B E Ryman. Biochim Biophys Acta 1982
46
18

Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial.
Harpreet S Bajaj, Richard M Bergenstal, Andreas Christoffersen, Melanie J Davies, Amoolya Gowda, Joakim Isendahl, Ildiko Lingvay, Peter A Senior, Robert J Silver, Roberto Trevisan,[...]. Diabetes Care 2021
15
18

Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans.
Thomas B Kjeldsen, František Hubálek, Claudia U Hjørringgaard, Tina M Tagmose, Erica Nishimura, Carsten E Stidsen, Trine Porsgaard, Christian Fledelius, Hanne H F Refsgaard, Sanne Gram-Nielsen,[...]. J Med Chem 2021
13
18

Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency.
B F Hansen, G M Danielsen, K Drejer, A R Sørensen, F C Wiberg, H H Klein, A G Lundemose. Biochem J 1996
174
18

LAPS Insulin115: A novel ultra-long-acting basal insulin with a unique action profile.
Nina Wronkowitz, Thorsten Hartmann, Sven Wolfgang Görgens, Daniela Dietze-Schroeder, Ira Indrakusuma, In Young Choi, Sung Hee Park, Young-Mi Lee, Se Chang Kwon, Yeonjoo Kang,[...]. Diabetes Obes Metab 2017
19
18

Trends in Insulin Use and Diabetes Control in the U.S.: 1988-1994 and 1999-2012.
Elizabeth Selvin, Christina M Parrinello, Natalie Daya, Richard M Bergenstal. Diabetes Care 2016
69
18

A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100.
Ildiko Lingvay, John B Buse, Edward Franek, Melissa V Hansen, Mette M Koefoed, Chantal Mathieu, Jeremy Pettus, Karolina Stachlewska, Julio Rosenstock. Diabetes Care 2021
9
22

Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial.
Inge B Halberg, Karsten Lyby, Karsten Wassermann, Tim Heise, Eric Zijlstra, Leona Plum-Mörschel. Lancet Diabetes Endocrinol 2019
67
18

Restoring normal islet mass and function in type 1 diabetes through regenerative medicine and tissue engineering.
Nicole A J Krentz, Lonnie D Shea, Mark O Huising, James A M Shaw. Lancet Diabetes Endocrinol 2021
3
66

BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study.
Tim Heise, Grégory Meiffren, Bertrand Alluis, Cyril Seroussi, Aymeric Ranson, Jorge Arrubla, José Correia, Martin Gaudier, Olivier Soula, Rémi Soula,[...]. Diabetes Obes Metab 2019
22
18


Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses.
M A Nauck, E Homberger, E G Siegel, R C Allen, R P Eaton, R Ebert, W Creutzfeldt. J Clin Endocrinol Metab 1986
583
18

A dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects.
A Khedkar, H Iyer, A Anand, M Verma, S Krishnamurthy, S Savale, A Atignal. Diabetes Obes Metab 2010
42
18

Selection of Small Molecules that Bind to and Activate the Insulin Receptor from a DNA-Encoded Library of Natural Products.
Jia Xie, Shuyue Wang, Peixiang Ma, Fei Ma, Jie Li, Wei Wang, Fengping Lu, Huan Xiong, Yuang Gu, Shuning Zhang,[...]. iScience 2020
16
18

'Smart' insulin-delivery technologies and intrinsic glucose-responsive insulin analogues.
Mark A Jarosinski, Balamurugan Dhayalan, Nischay Rege, Deepak Chatterjee, Michael A Weiss. Diabetologia 2021
19
18

Advances in Subcutaneous Delivery Systems of Biomacromolecular Agents for Diabetes Treatment.
Chen Li, Long Wan, Jie Luo, Mingyan Jiang, Keke Wang. Int J Nanomedicine 2021
5
40

New closed-loop insulin systems.
Charlotte K Boughton, Roman Hovorka. Diabetologia 2021
36
18

How insulin engages its primary binding site on the insulin receptor.
John G Menting, Jonathan Whittaker, Mai B Margetts, Linda J Whittaker, Geoffrey K-W Kong, Brian J Smith, Christopher J Watson, Lenka Záková, Emília Kletvíková, Jiří Jiráček,[...]. Nature 2013
223
18

Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3.
R M Bergenstal, H Lunt, E Franek, F Travert, J Mou, Y Qu, C J Antalis, M L Hartman, M Rosilio, S J Jacober,[...]. Diabetes Obes Metab 2016
36
18

Hepatoselectivity and the evolution of insulin.
R Herring, R H Jones, D L Russell-Jones. Diabetes Obes Metab 2014
49
18

Smarter Modeling to Enable a Smarter Insulin.
Simeon I Taylor, Richard D DiMarchi. Diabetes 2020
7
28

Oral insulin and buccal insulin: a critical reappraisal.
Lutz Heinemann, Yves Jacques. J Diabetes Sci Technol 2009
74
18

Structural biology of insulin and IGF1 receptors: implications for drug design.
Pierre De Meyts, Jonathan Whittaker. Nat Rev Drug Discov 2002
422
18

X rays and the structures of insulin.
D C Hodgkin. Br Med J 1971
5
40

The evolution of insulin therapy.
Philip Home. Diabetes Res Clin Pract 2021
10
20

Basal and 24-h C-peptide and insulin secretion rate in normal man.
Y T Kruszynska, P D Home, I Hanning, K G Alberti. Diabetologia 1987
99
18

Better glycaemic control with BioChaperone glargine lispro co-formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetes.
Grégory Meiffren, Theresa Herbrand, Ernestos Anastassiadis, Oliver Klein, J Hans DeVries, Tim Heise, Bertrand Alluis, Claire Mégret, Martin Gaudier, Olivier Soula,[...]. Diabetes Obes Metab 2019
3
66

Clinical Evaluation of MK-2640: An Insulin Analog With Glucose-Responsive Properties.
Alexander W Krug, Sandra A G Visser, Kuenhi Tsai, Bhargava Kandala, Craig Fancourt, Bob Thornton, Linda Morrow, Niels C Kaarsholm, Harold S Bernstein, S Aubrey Stoch,[...]. Clin Pharmacol Ther 2019
18
18

Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies.
Devin V McAllister, Ping M Wang, Shawn P Davis, Jung-Hwan Park, Paul J Canatella, Mark G Allen, Mark R Prausnitz. Proc Natl Acad Sci U S A 2003
388
18

Pharmacokinetics and Pharmacodynamics of Insulin Tregopil in Relation to Premeal Dosing Time, Between Meal Interval, and Meal Composition in Patients With Type 2 Diabetes Mellitus.
Anand Khedkar, Harold Lebovitz, Alexander Fleming, Alan Cherrington, Vinu Jose, Sandeep N Athalye, Ashwini Vishweswaramurthy. Clin Pharmacol Drug Dev 2020
11
18

Insulin Mimetic Peptide Disrupts the Primary Binding Site of the Insulin Receptor.
Callum F Lawrence, Mai B Margetts, John G Menting, Nicholas A Smith, Brian J Smith, Colin W Ward, Michael C Lawrence. J Biol Chem 2016
18
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.